Compremium
Quantis CVP
Invasive Accuracy
Non-invasively
Compremium Quantis CVP is for investigational use only and is not currently available for commercial use.
Central Venous Pressure (CVP)
A vital parameter that offers key context on venous return and right-heart loading which supports fluid and hemodynamic decisions.
CVP in Critical Scenarios
CVP is relevant in acute and chronic conditions but not easily accessible.
Today, measuring CVP has limitations
The invasive central line is the current gold standard for accurately measuring CVP. However, this invasive measurement comes with risks and complications such as infection, thrombosis and time to measurement.
Gold Standard
Proxy
What if you could
measure CVP
non-invasively –
measure CVP
non-invasively –
with the accuracy
of a central line?
of a central line?
Introducing the
Compremium Quantis CVP
A next-generation non-invasive approach to measuring Central Venous Pressure.
Invasive accuracy, non-invasively.
Invasive accuracy, non-invasively.
Compremium Quantis CVP is for investigational use only and is not currently available for commercial use.
Accurate, quick and easy to use
r = 0.95
Correlation to gold standard
(Thalhammer C. et al., 2007)
30 Seconds
Time to measurement
<1 hour
of training required
Enhanced usability powered by AI
Reduced variability
Shorter exam time
Improved diagnostic confidence
Presenting clear advantages over existing alternatives
A responsible role in care
The Compremium Quantis CVP aims to enable clinicians to reliably measure and monitor Central Venous Pressure non-invasively. Its role is to provide objective context to inform medical decision making when and where it matters.
Compremium Quantis CVP is for investigational use only and is not currently available for commercial use.
Compremium Quantis CVP is for investigational use only and is not currently available for commercial use.
Contact us for more information on this solution.
Thalhammer C. et al. "Non-invasive central venous pressure measurement by controlled compression sonography at the forearm." Journal of the American College of Cardiology (2007)
Swiss engineered
2026 Compremium AG
Follow us on LinkedIn